Loading...

Rituximab in Relapsing and Progressive Forms of Multiple Sclerosis: A Systematic Review

BACKGROUND: Rituximab is an anti-CD20 monoclonal antibody approved for non Hodgkin lymphoma and rheumatoid arthritis. It is being considered for the treatment of MS. OBJECTIVES: To evaluate the efficacy and safety of rituximab for MS treatment. DATA COLLECTION: Studies were selected if they were cli...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Castillo-Trivino, Tamara, Braithwaite, Dejana, Bacchetti, Peter, Waubant, Emmanuelle
Format: Artigo
Sprog:Inglês
Udgivet: Public Library of Science 2013
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3699597/
https://ncbi.nlm.nih.gov/pubmed/23843952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0066308
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!